While clinical studies suggest depressed patients may be more vulnerable to pain, experimental research is equivocal. This meta-analysis aimed to clarify whether depression is associated with altered pain perception in response to noxious stimulation and to identify factors that might influence this association. A search of major electronic databases was conducted to identify experimental studies investigating pain response in depressed participants vs. healthy controls using established pain outcome measures. Random effects meta-analysis of standardized mean differences was conducted on data from 32 studies (N=1,317). For high-intensity noxious stimulation, overall pain tolerance was similar across depressed and control groups (Hedge's g=0. 09, p=0.71, studies=10). For low-intensity stimulation, a small, but statistically significant higher mean sensory threshold (g=0.35, p=0.01, studies=9) and pain threshold (g=0.32, p=0.02, studies=25) was observed in depressed participants, suggesting diminished pain. However, considerable heterogeneity in the direction and magnitude of effects was observed, indicating a likely condition-specific impact of depression on pain. Subgroup analysis found that pain threshold/tolerance was increased in depression for exteroceptive (cutaneous) stimulation but decreased for interoceptive (ischemic) stimulation, but that substantial heterogeneity remained. Overall, results provide some support for altered pain processing in depression, but suggest this link is dependent upon modality and additional, unidentified factors.
Introduction
Depression and pain are frequently observed as comorbid conditions in clinical settings.
They represent two of the leading predictors of years lived with disability across the world 73 , and appear to interact to prove costlier and more disabling than the sum of their individual effects 2 . Patients with depression often present with medically unexplained somatic complaints, such as abdominal pain, back pain and headache 35 , with mean pain prevalence estimated as 65% 2 compared to around 29% for non-depressed populations 15 . Moreover, the presence of depression may predict future musculoskeletal pain 40 and is a key risk factor for chronic low back pain 53 suggesting a causal influence. The biochemical theory of depression suggests that a neurochemical imbalance of monoamines (e.g. serotonin)
underlies depression and, given that these neurotransmitters are likely to play a key role in modulatory pain pathways, this may lead to altered pain perception 2, 27 . Neural mechanisms common to depression and pain have also been implicated, with areas of the brain linked to mood (e.g. amygdala, insular) also sending numerous projections to key structures involved in pain modulation (e.g. periaqueductal gray) 2, 22 .
If pain perception abnormalities are a manifestation of depression, this may have important treatment and diagnostic implications. For example, Fishbain et al. 24 found that the impact of antidepressant medication on depression response/remission may be impaired when pain is present. Pain may also influence diagnostic accuracy, with failure to accurately diagnose major depression by physicians estimated to exceed 50% 31, 46 , with presence of painful symptoms being central to misdiagnosis 13, 32 . One large review found that 69% of individuals experiencing depression tended to disclose only somatic symptoms 59 , explaining why depression is frequently misdiagnosed as a somatic illness 71 . The consequences of failing to recognize depression can be severe, as untreated depression often becomes worse, leading to poorer outcomes 55 .
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Pain perception abnormalities in depression have also been examined using experimental paradigms to provide a level of control difficult to achieve in clinical settings, and to facilitate the assessment of pain across multiple dimensions, including subjective, behavioral and psychophysiological responses. Surprisingly, a preliminary meta-analysis of six experimental studies 16 found decreased pain in depressed groups relative to healthy controls. Whilst informative, a considerable number of studies have been conducted since the publication of the original review 13 years ago. Furthermore, limited data availability restricted the review to an examination of pain threshold only, which assesses minimal intensity pain 75 , and which in isolation is of limited clinical relevance. Since this review, there has been mounting interest in depression and pain perception with many experimental studies conducted over the past decade, producing equivocal findings. One possible explanation for this equivocality is that the link between depression and pain perception may be dependent upon the type of noxious stimulus used, with one theory 37 suggesting that different sources of pain (e.g. exteroceptive vs. interoceptive) are subserved by distinct pain inhibitory systems and these can be affected differentially by depression. While preliminary evidence appears to supports this theory, the influence of stimulus modality as a possible moderator has yet to be subject to systematic review. To better understand the link between depression and pain, there is a pressing need to provide an updated review and synthesis of the recent experimental pain literature, examining potential moderators and more clinically relevant measures, such as pain tolerance 75 , pain affect and pain intensity ratings.
Therefore, we conducted a comprehensive systematic review and meta-analysis comparing depressed and healthy control groups in their response to experimentally-induced pain.
Specific aims were to examine: (1) whether depressed vs. healthy controls differed in sensitivity to experimentally-administered noxious stimuli, (2) whether differences would M A N U S C R I P T
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Method
This systematic review was conducted in accordance with the MOOSE guidelines 64 and the PRISMA statement 47 .
Eligibility criteria
Studies were included that utilized: (1) a group with current depression, as defined by a primary diagnosis of a depressive disorder based on a clinical instrument (e.g. DSM, ICD) or a standardized questionnaire (e.g. the Beck Depression Inventory); (2) a comparative control group of healthy, non-depressed individuals; (3) an experimental sensory stimulus; and (4) at least one of the following outcome measures: pain threshold, pain tolerance, pain ratings or sensory threshold.
Studies were excluded if: (1) depression was a secondary diagnosis, (2) depressed groups suffered from a chronic pain condition, (3) classification as depressed was based on experimental mood induction, or (4) pain perception was assessed during an experimental manipulation of mood or attention.
Information sources and search details
Two independent reviewers (KG, TT) searched EMBASE, MEDLINE, PsycINFO and the Web of Science from database inception until 7 th April, 2015. Our search used a widely inclusive strategy, identifying articles that contained appropriate combinations of broad and specific keywords relating to eligibility criteria; precise search term combinations are reported in Table S1 along with number of hits returned for the Medline database as an exemplar. Due
to the large number of results, studies reporting randomized clinical trials were excluded and the search results were refined using limits of human studies and English language.
Additional studies were identified from reference lists of relevant articles.
Study selection
After removal of duplicates, two reviewers (KG, TT) screened titles and abstracts for eligibility, and developed a list of full text articles through consensus. Two authors (TT, BS) considered the full texts of included articles and a final list of eligible articles was agreed. We contacted authors up to 3 times over a month to clarify study eligibility and/or acquire additional data.
Outcomes
Multiple primary outcomes were used to capture different aspects of pain response 25 : (1) pain threshold (the point at which pain is first perceived), (2) pain tolerance (the point at which pain can no longer be tolerated), and (3) self-reported ratings of pain intensity/affect.
Sensory threshold (the point at which sensation is first perceived) was included as a secondary outcome to investigate whether differences in pain perception were accompanied by differences in non-painful sensory perception.
Data Extraction
Study data were extracted independently by two authors (TT, KG) using a standardized extraction form that we have used in several of our previous studies 65, 66 but with a few, relatively minor adaptations for the topic of depression and pain perception, so coding protocols were very clear and unambiguous. Details were recorded for pain induction method, pain assessment outcome, depressed group (demographics, diagnostic method, symptom severity, antidepressant medication), control group (demographics), study design
and geographical location. We recorded group means and standard deviations for each pain outcome measure, or any other available information that would allow computation of effect size (see 'Meta-Analysis' section below). To minimize reporting bias, authors were also contacted for statistical details when non-significant findings were reported but in insufficient detail to allow computation of effect sizes.
When a study reported pain outcome data at different time points, we extracted averaged data if available, otherwise we extracted data at the first time point. When outcome data were collected at multiple stimulus intensities (usually applicable to electrical stimulation), the highest intensity was extracted as this was most likely to reliably evoke pain. When a study applied noxious stimulation to both left and right sides of the body, we used pain scores averaged across sites where possible, otherwise we extracted data from the right side as this was the most common site tested and may show greater sensitivity to detecting differences in pain response and increased homogeneity in our analyses 4 . From studies reporting pain data in participants before and after antidepressant treatment, we used unmedicated data for the overall pooled analyses, but we used data from treated patients for the medicated/unmedicated subgroup analysis. Finally, a few studies used sensory decision theory to yield two measures of pain threshold: response criterion and d-prime (sensory discrimination). Response criterion was abstracted as the data of interest, as this measure is the most closely related to verbally declared pain threshold used in the other included studies 25 .
Methodological study appraisal
Two authors (TT, BS) independently completed methodological quality assessment of included articles using the case-control Newcastle Ottawa Scale 74 (NOS). If any M A N U S C R I P T
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Each study receives an overall score for methodological quality of up to 9 points (one for each item) and scores of 5 and above are considered to reflect satisfactory study quality
74
.
Meta-analysis
As we anticipated heterogeneity in effect sizes due to variation in important study characteristics typical in experimental pain research, a random effects model using the method of moments was chosen. This allows heterogeneity to be accounted for statistically and permits generalization to studies beyond those examined in the meta-analysis. Hedges's g was calculated as the effect size based on standardized differences in pain scores between participants with depression and controls. All analysis was performed using Comprehensive Meta-Analysis software (CMA, version 3). When computing Hedge's g, if a study used multiple pain inductions we used the averaged pain score, or if this was not available, we used scores for heat/cold or electrical modalities, as these were the most commonly reported (as the choice of these modalities might have some influence on the overall effect size, we also computed effect sizes for each stimulus modality separately in subgroup analysis). If a study reported data from participants before and after anti-depressant medication we included only unmedicated data for overall analyses. Analysis of pain ratings was performed only for studies where stimulation intensity was equivalent for both groups (i.e. equal time/temperature), to avoid confounding of differences in pain ratings with differences in stimulus intensity. Analysis was conducted as described below. . If we encountered publication bias, we calculated the trim and fill adjusted analysis 17 to remove the most extreme small studies from the positive side of the funnel plot, and recalculated the effect size at each iteration, until the funnel plot was symmetric around the new effect size.
Second, we conducted subgroup analysis for pain threshold and tolerance (limited data prohibited subgroup analysis of other outcomes). As a primary interest was to determine whether depressed vs. control group differences were influenced by stimulus modality, we conducted separate analyses for each modality. We used Cochran's Q to test for overall differences in effect size across modalities, and if significant, used follow-up Z-tests to compare each individual modality vs. every other modality 11 . We also performed separate analysis for medicated/unmedicated subgroups, and examined whether results were similar when restricting the sample to patients with major depressive disorder (MDD) only.
Third, we performed meta-regression analysis to examine whether group differences were influenced by mean study age, gender composition and magnitude of depressive symptoms in the depressed group. Generally, meta-regression was performed only when at least 10 M A N U S C R I P T
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Finally, for studies that assessed pain perception before and after antidepressant treatment, we pooled within-subject changes in each pain outcome measure using pre and post means and SDs for both groups in order to assess the effect of antidepressant treatment on pain measurements.
RESULTS
Study characteristics
Initial searches yielded 5095 unique hits including 4 records identified through manual searching of reference lists. After screening, 65 articles were retained for full text review of which 33 were excluded (see Figure 1) . Altogether, 32 studies were retained for analysis (Table 1 ). Table 1 here Across the 32 retained studies there were 30 unique studies with an aggregated total of 1317 participants (depression n=641, control n=676). The two non-unique studies 48, 62 were linked to two companion papers 56, 63 that used the same sample but provided different 26 (k=13), followed by the BDI (k=10).
Figure 1 here
Antidepressant treatment status was reported as either unmedicated (k=16), fully medicated (k =6) or mixed medicated/unmedicated (k=7), with two studies providing data on the same sample before and after antidepressant treatment 4, 5 . Three studies did not report medication status. A study average of 31.4% (range 0-100) of depressed patients were treated with antidepressants at baseline (19 studies provided this information). The following pain induction methods were used: heat (k=17), cold (k =7), electrical (k =8), ischemia by tourniquet procedure (k =6), pressure (k =4), laser (k =1).
Mean total NOS score across studies was 5.1 with a range of 4-6 (Table 1 ). Individual quality criteria least frequently addressed included participant selection and experimenter blinding.
More specifically, several studies employed hospital controls and many studies provided 
Meta-analysis results
Details of all meta-analysis results are presented in Table 2 , with key findings for each outcome measure summarized below.
Pain threshold
In (Table 2) did not noticeably diminish (with the possible exception of the cold stimulus), suggesting that considerable heterogeneity remains even when stimulus modality is accounted for.
Meta-regression of pain threshold
In meta-regression analysis, depressive symptom severity (analyzing only studies that used the HAM-D, which was most commonly employed rating scale, in order to increase homogeneity of the findings), sex, age or study quality (NOS scores) were not significantly related to group differences in pain threshold (k=12-25 studies, β=.00-.24, p=0.14-0.99); see Table S2 for full results. Meta-regression was not performed on duration of illness as only 6
pain threshold studies provided this data. 
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Meta-regression of moderators of pain tolerance
Although no overall group differences in pain tolerance were found in the previously reported meta-analysis, meta-regression was conducted to examine whether group differences might be influenced by age, gender or study quality. However, differences between depressed and control groups were not significantly moderated by any of these variables (Table S2) .
Pain ratings
Pooling data from 155 people with depression and 193 controls across 8 studies yielded no significant between-group differences in ratings of pain intensity (g=0.00, 95% CI [-0.37, 
Sensory threshold
Pooling data from 9 studies, including 178 people with depression and 178 controls, sensory threshold was significantly higher in people with depression, g=0.35, 95% CI [0.08, 0.62], p=0.01 ( Figure S2 ). There was some evidence of publication bias (Egger=4. 
Discussion
The current review is the largest and most comprehensive meta-analysis investigating responses to experimentally-induced pain in people with depression vs. healthy controls. Our findings of elevated overall pain threshold in depression confirm and extend preliminary findings from a previous meta-analysis of 6 experimental studies 16 , but in a much larger pool of 25 pain threshold studies. Small overall effect sizes were observed in both the current (g=0.32) and previous meta-analysis (d=0.38). Additionally, we were able to examine a wider range of assessment measures than the previous review, including pain tolerance. Although there were fewer studies of tolerance available relative to threshold studies, there was little M A N U S C R I P T
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17 evidence of any link between depression and suprathreshold pain, with no significant differences in pain tolerance (g=0.09) found. These findings suggest that depression may be associated with a general decreased sensitivity to low intensity stimulation, but not to higher intensity stimulation (e.g. that producing tolerance level of pain). The possibility of increased thresholds in depression is consistent with attentional pain processing models 19 .
These state that limited attentional resources are competed for by painful and other, nonpainful stimuli. If greater attention is devoted to non-painful stimuli (e.g. environmental stimuli/internal thoughts), as has been observed in depression 45 , this should reduce pain by denying it attentional resources; especially for mild pain, which is of relatively low attentional priority. Dickens et al. 16 pointed out that these models would explain the increased pain threshold they found in depressed participants, but should also predict little difference for higher intensity pain which commands greater attention. While the authors were unable to test this hypothesis due to lack of tolerance data, this hypothesis appears to be confirmed by our results which offer further support for current attentional models.
An important caveat in interpreting the association between depression and pain threshold is that considerable heterogeneity was observed. Studies varied both in the magnitude and direction of effects, suggesting that conclusions regarding a generalized effect of depression on pain perception are overly simplistic, and that any such effect may depend upon complex constellations of other moderating factors. Based on the current findings, diminished pain perception cannot be considered a reliable marker of depression.
A key finding was that the depression-pain link appears to be strongly influenced by the type of pain induced. Whereas depression was associated with reduced or no alteration of pain for most modalities (e.g., heat, cold, electrical), depressed participants exhibited increased pain in response to ischemic induction. These differences in responses across modalities are consistent with the wider pain literature exhibiting typically weak M A N U S C R I P T , it may be that experimental findings simply do not generalize outside of the laboratory. However, the fact that depression is associated with increased pain for ischemic (and clinical) pain but with decreased/unaltered pain for other inductions, could contribute to our understanding of the discrepancy between experimental and clinical findings. First, experimental studies typically rely on exteroceptive stimulation of the skin 44 (the cold pressor also provides stimulation of both deeper and peripheral structures, although stimulation of deeper structures is far less pronounced, and several studies examined here used a skin contact thermode to induce cold). Both ischemia and clinical pain, however, are evoked through interoceptive pathways by nociceptors innervating deep structures 57 (e.g. muscle, joints), involve greater C-fiber recruitment and are subject to greater modulation from descending pain inhibitory pathways 57 . Second, pain is a multidimensional experience involving sensory, cognitive and affective components 43 , and it may be that depressed individuals react more negatively to pain with a stronger affective component. Clinical pain is more distressing than typical experimental pain, and ischemic pain is often more severe, diffuse and uncontrollable than noxious skin stimulation 43 , so may produce greater negative affect (although too few studies recorded pain affect to evaluate this statistically). While the suggestion that the depression-pain link may be influenced by pain affect or its interoceptive/exteroceptive origin is necessarily speculative, it represents a plausible explanation for the discrepancies in findings across different modalities and clinical reports that warrant further empirical investigation.
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If any effects of depression are influenced by modality, pinpointing possible underlying mechanisms is largely speculative, given a lack of appropriate empirical data. One possible explanation is provided by Lautenbacher and Krieg's global theory of pain processing in psychiatric disorders 37 , and speculates that neurotransmitter dysfunction in depression affects pain perception in two ways. First, by diminishing spinal and subcortical processing which reduces processing of all sensory input therefore elevating sensory/pain thresholds.
Second, by disrupting descending pain pathways which inhibit sustained or endogenous (e.g., ischemic) pain, thus heightening pain of endogenous origin. However, while there is some evidence that the areas of the brain involved in mood regulation also regulate pain pathways 77 , more empirical data are needed to convincingly demonstrate that depression selectively modulates pain processing in this way.
There is also tentative evidence to suggest that any putative effect of depression on pain could be influenced by anti-depressant medication. The two prospective studies found that the greater sensory and pain thresholds exhibited by depressed patients relative to controls were diminished following antidepressant treatment. In addition, the increased pain threshold observed in depressed participants was significant only in the unmedicated and not in the anti-depressant medicated group. However, given the minimal difference in effect size and the greater power of the unmedicated analysis from more available studies, this finding must be considered entirely preliminary. Nevertheless, since several neurotransmitters believed to be involved in the pathophysiology of depression are also involved in pain, e.g. serotonin, noradrenalin 2 , it would perhaps be unsurprising that modulation of these neurotransmitters might restore not only mood but also sensory/pain threshold gating. Further data is, however, clearly needed to support any potential effect of anti-depressant medication.
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Several limitations of the current review should be noted. First, considerable study heterogeneity was observed which could not be resolved by study differences in symptom severity, gender, age or study quality. Given this heterogeneity, caution in interpreting findings must be applied, especially where confidence intervals are relatively broad.
Additionally, although significant differences in effect size across stimulus modalities were observed, there is little evidence that modality offers any substantive resolution of this heterogeneity. It seems likely that important moderators of the relationship between depression and pain perception exist (e.g., methodological, use/non-use of chronic pain patients) but remain unidentified. Second, while factors such as the endogenous nature of ischemic pain represent one theoretically plausible reason for differences across ischemic and other stimuli, other confounding characteristics (e.g. stimulus duration) may offer alternative explanations for these differences. Third, fewer studies investigating pain tolerance (k=10) were available for analysis compared to pain threshold (k =25). The lack of significant overall tolerance differences is unlikely to be attributable to reduced power, however, as the aggregated tolerance sample was still large (N=375) and the effect size close to zero. Finally, only experimental pain studies were examined and therefore the current findings may have limited generalizability to clinical pain.
Further research should be conducted to help elucidate reasons for inconsistency across study findings and identify potential moderators, such as pain duration 54 and negative pain affect 30 , which have been suggested to influence the relationship between depression and chronic pain. In addition, measurement and/or careful control of variables likely to differ across ischemic and other pain inductions (e.g., stimulus contact time and negative affect), could help explain why differences across modalities were observed. Additional studies employing within-group designs, where individual variability can be controlled, could directly compare ischemic and cutaneous pain inductions to provide further supporting evidence for M A N U S C R I P T
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21 the role of modality. Future studies should also attempt to improve study quality by striving to acquire representative samples for depressed and control participants (e.g. avoiding hospital controls) and providing clearer descriptions of recruitment procedures.
In summary, this is the largest and most comprehensive meta-analysis of experimental pain induction studies in individuals with depression to date and suggests two key findings. First, there is some evidence that depression may be associated with an overall reduced perceptual sensitivity to low, but not high intensity stimulation. However, this overall effect is relatively small and considerable variation in study findings indicates that diminished pain may only be evident under certain, partly unidentified conditions. Second, any putative
impact of depression appears to be strongly influenced by modality, with depressed participants showing increased pain in response to ischemic stimulation, but reduced or unaltered pain perception in response to other stimulus modalities. This finding is consistent with theory proposing different neural pathways for interoceptive and cutaneous-based pain and suggests that depression could affect these pathways differentially. Overall, these findings provide support for a relationship between depression and pain, but indicate that this relationship is complex and deserves further research that pays particular attention to variability due to stimulus intensity and modality as well as additional moderating variables. 
Highlights
• Meta-analysis of 32 experimental pain studies compared depressed vs. controls
• Higher overall pain threshold in depression but strong heterogeneity evident
• No differences in pain tolerance
• Depression and pain link may be dependent upon type of pain stimulation
